A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma

Teri N. Kreisl, Weiting Zhang, Yazmin Odia, Joanna H. Shih, John A. Butman, Dima Hammoud, Fabio M. Iwamoto, Joohee Sul, Howard A. Fine

Research output: Contribution to journal › Article › peer-review